The smart Trick of LY 3000328 That No One is Discussing
All enrolled sufferers who obtained at least a single dose of zosuquidar or placebo during induction have been monitored for that prevalence of adverse occasions (439 sufferers, 219 on zosuquidar and 210 on placebo). The commonest adverse situations had been connected with the duration of prolonged and considerable myelosuppression as is predicted